Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

SB reports on potent analgesics with fewer side effects

Sep. 11, 1998

DuPont identifies SP-904 as potent and selective CRF1 receptor antagonist

Sep. 11, 1998

Synthesis and SAR for piperidine SSNRAs reported at ACS by Parke-Davis/CoCensys

Sep. 10, 1998

New anticonvulsant series developed from SB-204269 at SKB

Sep. 10, 1998

Dopamine D3 antagonist with improved selectivity, clearance discovered at SB

Sep. 10, 1998

Dutch academics identify free radical scavengers/xanthine oxidase inhibitors

Sep. 10, 1998

Taisho and Nihon Nohyaku describe development of potential new antipsychotics at ACS meeting

Sep. 9, 1998

Fujisawa prepares new urea derivatives as 5-HT antagonists

Sep. 9, 1998

Vanguard Medica, Roche to collaborate on development of endothelin antagonist

Sep. 9, 1998

Schwarz to market rectal morphine product developed by Core

Sep. 8, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 12, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
LINC01116 has prognostic value in lung cancer, study shows
BioWorld Science
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...